Zymvol Biomodeling has appointed Fredrik Olrog as Chief Operating Officer. The appointment marks a significant step in the company's evolution from a scientist-led computational platform towards a structured, execution-driven business capable of scaling its enzyme engineering products across European and international markets.

“The team at Faraday was very professional, listened to our feedback and proposed professionals which were aligned with our expectations.”

- Maria Fátima Lucas, Founder & CEO of Zymvol.

The computational enzyme engineering company applies proprietary AI and molecular simulation technology to design and optimise enzymes for customers in industrial and pharmaceutical sectors. The company operates through partnerships with manufacturing and CDMO networks and is advancing a pipeline of high-margin, IP-led products.

Fredrik joins from MINE STORAGE, where he has served as CEO since 2025. His career spans close to two decades across science- and technology-driven businesses. He served as CFOO at enginzyme from 2021 to 2025, where he held combined commercial and financial leadership responsibilities. Prior to that, he co-founded Biond AB in 2011 and led it as CEO until 2020, guiding the company through its formative years and into a period of structured growth. Earlier roles include VP North America at St1 Biokraft, VP Sales at Biokraft, and commercial positions at GE Capital. In his new role, Fredrik will serve as the primary operational and commercial partner to Founder and CEO Maria Fátima Lucas, taking ownership of execution, business development, financial discipline and the processes that connect the company's scientific capabilities to its commercial milestones.

“Faraday prepared me for every stage of the process. They knew Zymvol’s business in real depth, from the science to the commercial priorities, and that came through in every conversation. When the offer came, I said yes with complete confidence in the role and the opportunity.”

- Fredrik Olrog, Chief Operating Officer of Zymvol.

This search assignment was led by Sonia Shah, Principal, and Andrew Banks, Managing Partner, with support from Trinity Kershaw, Analyst, at Faraday Partners, in collaboration with Maria Fátima Lucas, Founder & CEO of Zymvol; John Nicols, Board Member at Zymvol; their wider leadership team, alongside their investors Pierre Monsan; Alexandre Barbosa  and Sofia Santos at Faber; Sebastian LeFebvre at Elaia; and Jonas Hornung at Übermorgen.

About Zymvol Biomodeling

Zymvol Biomodeling is a computational enzyme engineering company helping industrial and pharmaceutical customers design and optimise enzymes through proprietary AI and molecular simulation technology. The company combines cutting-edge computational methods with deep biochemical expertise to help customers accelerate development timelines and access high-performance enzymatic solutions.

Zymvol is backed by Pierre Monsan, Faber (Sofia Santos and Alexandre Barbosa), Elaia (Sebastian LeFebvre) and Übermorgen (Jonas Hornung).

About Faraday Partners

Faraday Partners is a global executive search firm supporting the most valuable companies in tech and their investors from early conviction to industry impact. We specialise in senior leadership appointments across all facets of leadership, helping organisations secure transformative leaders who scale businesses, drive innovation, and create long-term enterprise value.